Yellow fever virus (YFV) is a re-emerging virus that can cause life-threatening yellow fever disease in humans. Despite the availability of an effective vaccine, little is known about the replication mechanism of YFV, and there are still no available specific anti-YFV medicines. Herein, by introducing the Renilla luciferase gene (Rluc) into an infectious clone of YFV vaccine strain 17D, we generated a recombinant virus 17D-Rluc.2A via reverse genetics approaches. The 17D-Rluc.2A had similar plaque morphology and comparable in vitro growth characteristics with its parental strain. Importantly, the reporter luciferase was efficiently expressed in 17D-Rluc.2A-infected mammalian and mosquito cells, and there was a good linear correlation between intracellular luciferase expression and extracellular infectious virion reproduction. Furthermore, by a combination of the 17D-Rluc.2A reporter virus and selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) technology, the conserved 5'-SLA element was shown to be essential for YFV replication, highlighting the capability of 17D-Rluc.2A in the investigation of YFV replication. At last, we demonstrated that two compounds with distinct anti-viral mechanisms can effectively inhibit the viral propagation in 17D-Rluc.2A-infected cells, demonstrating its potential application in the evaluation of anti-viral medicines. Taken together, the 17D-Rluc.2A serves as a useful tool for the study of YFV replication and anti-YFV medicine development.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692546 | PMC |
http://dx.doi.org/10.1007/s12250-021-00428-1 | DOI Listing |
Cells
February 2025
Institute of Virology and Immunobiology, University of Würzburg, Versbacher Str. 7, 97078 Würzburg, Germany.
Cellular metabolism must adapt rapidly to environmental alterations and adjust nutrient uptake. Low glucose availability activates the AMP-dependent kinase (AMPK) pathway. We demonstrate that activation of AMPK or the downstream Unc-51-like autophagy-activating kinase (ULK1) inhibits receptor-mediated endocytosis.
View Article and Find Full Text PDFWhile excess rainfall is associated with mosquito-borne disease because it supports mosquito breeding, drought may also counterintuitively increase disease transmission by altering mosquito and host behavior. This phenomenon is important to understand because climate change is projected to increase both extreme rainfall and drought. In this study, we investigated the extent to which seasonally-driven mosquito and primate behavior drove the first urban yellow fever virus (YFV) epidemic in Brazil in a century, coinciding with an equally rare drought, and to assess the role of interventions in ending the outbreak.
View Article and Find Full Text PDFPerspect Biol Med
March 2025
Over millennia, epidemics have wielded as much sway over human affairs as have wars, economic crises, and political upheavals. Devastating epidemics in the past have changed the course of history. This article focuses on the yellow fever epidemic of 1802 in St.
View Article and Find Full Text PDFJ Med Case Rep
March 2025
The First Medical Center, Department of Neurology, Chinese PLA General Hospital, Fuxing Road 28, Haidian District, Beijing, 100853, China.
Background: Acute necrotizing encephalopathy is a rare, clinically distinct subgroup of acute encephalopathy, which may be a complication of coronavirus disease 2019.
Case Presentation: A 22-year-old male of Han Chinese with a yellow complexion presented with fever, psychological and behavioral abnormalities, seizures, and coma. Cerebrospinal fluid tests indicated leukocytosis, high protein concentrations, and significantly elevated levels of neuron-specific enolase, interleukin-2, interleukin-6, and interleukin-8.
Microbiol Spectr
March 2025
Global Clinical Immunology, Sanofi, Swiftwater, Pennsylvania, USA.
Unlabelled: The plaque reduction neutralization test (PRNT) has been used widely for the detection and quantitation of yellow fever (YF) virus-neutralizing antibodies in human serum; however, it is labor-intensive and challenging to adapt to high-throughput clinical testing needed for vaccine licensure. Here, we describe the development and validation of a new Vero cell-based YF microneutralization (MN) assay, with immunostaining readout, for the detection and quantification of YF virus-neutralizing antibodies in human serum. Comparison of neutralizing antibody titers measured with the YF MN assay versus the historical YF PRNT, based on a 50% reduction in plaque counts (PRNT), demonstrated 100% serostatus agreement at a titer of 10 (1/dil) in participants with a history of YF vaccination.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!